Andrea Serio.

Andrea Serio

Andrea first trained in Biotechnology at the University of Padova in 2003, before moving to the Università Vita-Salute San Raffaele of Milan in 2006 to pursue a MSc in Medical and Cellular Biotechnology.

He then joined the University of Edinburgh in 2009, where he was awarded a studentship to work on patient-derived induced pluripotent stem cells (iPSCs) platforms to model glial neuronal interactions in genetic forms of Amyotrophic Lateral Sclerosis (ALS).

After obtaining his PhD he then joined Prof. Molly Stevens lab at Imperial College London in 2013 as a postdoctoral research associate, and worked on establishing novel modelling platforms for neural circuits combining stem cell differentiation, tissue engineering and novel imaging approaches.

He was appointed a lectureship at King's College London in September 2017, and moved to the Francis Crick institute in Nov 2019 for his secondment, where he has now established the neural circuit bio-engineering (NCB) group.